Jinlong capsule combined with interventional therapy for primary hepatocellular carcinomas: a clinical analysis on 150 patients
10.3760/cma.j.issn.1007-8118.2013.07.012
- VernacularTitle:金龙胶囊联合介入治疗原发性肝癌150例临床分析
- Author:
Bin LI
;
Lixin ZHAO
;
Zhiwei LIU
;
Lei LI
;
Longbin MA
;
Zhixiang ZHOU
;
Wanning HU
- Publication Type:Journal Article
- Keywords:
Jinlong caspule;
Primary hepatocellular carcinoma;
Interventional therapy
- From:
Chinese Journal of Hepatobiliary Surgery
2013;19(7):530-533
- CountryChina
- Language:Chinese
-
Abstract:
Objective To analyze the results on patients with primary hepatocellular carcinoma who received Jinlong capsule combined with interventional therapy or interventional therapy alone.Methods During the period from March 2003 to October 2012,147 patients with primary hepatocellular carcinoma were treated in Tangshan People's Hospital with interventional therapy.These patients were randomly divided into two groups:combined interventional group (n=74) and interventional alone group (n=73).Results Compared with the interventional therapy alone group,the efficacy,quality of life,and the liver function using the Child-Pugh classification were significantly better in the combined interventional therapy group for tumor less than 5 cm (P＜0.05) than the interventional alone group.The combined interventional therapy group was also significantly better than the interventional alone group in WBC count (P＜0.05).Conclusion Jinlong capsule combined with interventional therapy was superior to interventional therapy alone for patients with primary hepatocellular carcinoma,especially when the tumor was less than 5 cm.
